Mobile-health Network Solutions Launches $300 Million At-the-Market Offering to Drive AI-Powered Healthcare and Pharmacy Delivery Expansion
Rhea-AI Summary
Mobile-health Network Solutions (NASDAQ:MNDR) has announced a $300 million At-the-Market (ATM) equity offering to fuel its expansion in AI-powered healthcare services. The company plans to utilize the proceeds for developing medical large language models (LLMs), expanding AI-driven teleconsultation services across Asia, and building pharmacy delivery infrastructure.
Led by Co-CEO Dr. Siaw Tung Yeng, MNDR aims to create a comprehensive healthcare ecosystem by combining intelligent diagnostics with pharmacy delivery capabilities, particularly focusing on underserved regions. Unused proceeds will be temporarily invested in investment-grade instruments, with detailed terms to be outlined in an upcoming SEC filing.
Positive
- Strategic $300 million ATM offering to fund expansion and technology development
- Development of specialized medical LLMs for improved diagnostic capabilities
- Expansion of AI-driven teleconsultation services across high-growth Asian markets
- Integration of pharmacy delivery infrastructure for end-to-end healthcare services
Negative
- Potential dilution of existing shareholders through ATM offering
- Significant capital requirements for infrastructure development and market expansion
- Execution risks in implementing AI technologies and pharmacy delivery systems
News Market Reaction 2 Alerts
On the day this news was published, MNDR declined NaN%, reflecting a moderate negative market reaction. Argus tracked a trough of -9.7% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Singapore, Singapore--(Newsfile Corp. - July 17, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading AI-powered digital health platform, today announced the launch of an At-the-Market (ATM) equity offering to raise up to US
The net proceeds from this offering will be allocated to several mission-critical initiatives, reinforcing Mobile-health's leadership in digital healthcare. Key focus areas include:
Development of advanced large language models (LLMs) customized for medical case assessment, enabling faster and more accurate diagnostics.
Expansion of AI-driven teleconsultation services, designed to improve doctor-to-patient ratios in underserved regions, with a primary emphasis on growth across Asia.
Acquisition and build-out of pharmacy delivery infrastructure, ensuring last-mile fulfilment of prescriptions generated through AI-assisted consultations, and delivering seamless continuity of care from triage to treatment.
"This ATM offering is a pivotal step in realizing our vision of a truly scalable, technology-enabled healthcare ecosystem," said MNDR Co-CEO Dr Siaw Tung Yeng. "By merging intelligent diagnostics with pharmacy delivery capabilities, we're empowering communities that lack traditional medical infrastructure with access to vital health services. This initiative reflects our unwavering commitment to democratizing care and advancing health equity - starting in Asia and extending globally."
Dr. Siaw added that, pending allocation decisions, any net proceeds from the offering not immediately deployed may be invested in short-term, interest-bearing, investment-grade instruments. The terms of the offering, along with specific use-of-proceeds details, he said, will be provided in the applicable prospectus supplement filed with the U.S. Securities and Exchange Commission (SEC).
About Mobile-health Network Solutions
Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.
Forward-Looking Statements
Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.
Important Information Regarding the Offering
This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any jurisdiction where such offer or sale is unlawful prior to registration or qualification. A registration statement on Form F-3 relating to the securities has been filed with the SEC but has not yet become effective. Offers and sales will only be made pursuant to a prospectus and related prospectus supplement. Investors are encouraged to review the Company's filings for full details.
For media inquiries, please contact:
Mobile-health Network Solutions Investor Relations Contact:
2 Venture Drive, #07-06/07 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.com
Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: info@skylineccg.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259024
FAQ
What is the size of Mobile-health Network Solutions' (MNDR) ATM offering in 2025?
How will MNDR use the proceeds from its 2025 ATM offering?
What is Mobile-health Network Solutions' strategy for AI implementation?
How will the MNDR ATM offering impact shareholders?
What is MNDR's plan for unused proceeds from the ATM offering?
